Long-term (three-month and one-year) follow-up of nasopharyngeal carriers of Neisseria meningitidis with a frequency of sample collection of once a week and once a month resp. in the healthy population with a mean age of 43 years revealed a 4.8% positivity (2 of 42 subjects). Carriership of the same phenotype and ET-genotype of the N. meningitidis group 29E was stable in one subject, while the other long-term carrier of N. meningitidis group B has changes of the phenotype as well as ET-genotype during the follow-up period. Double (after a 3-month interval) verification of the seroprevalence of specific antimeningococcal antibodies revealed in a group of immunized subjects (vaccine A and C) a considerable degree of anti A immunity. Anti A-seropositivity in subjects immunized within a three-year interval since vaccination was 100%, in those immunized within a four-year interval a decline to 66% was recorded. Anti C antibodies after vaccination within a three-year interval were recorded in 75% subjects, in vaccinated subjects the authors detected antibodies during the first year after vaccination in 86% of the subjects. Natural anti A antibodies of the lowest titre 1:6 were recorded in four non-vaccinated subjects (22%). Naturally acquired anti B antibodies (B:2a:P1.2,P1.5) and anti C (C:2a:P1.2,P1.5) were not detected in any of the subjects.
Download full-text PDF |
Source |
---|
J Am Soc Nephrol
January 2025
Nephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Pulmonology
December 2025
Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Centre de Référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Ile-de-France, Centre et Martinique. Service de Médecine Interne 2, Paris, France.
Clin Rheumatol
January 2025
Department of Pulmonology & Interventional Pulmonology, Caritas Hospital and Institute of Health Sciences, Thellakom, Kottayam, Kerala, India.
Rheumatoid arthritis (RA) is a systemic, progressive illness marked by persistent synovitis that causes substantial functional disability. Treatment delays frequently affect health-related quality of life. Extra-articular features are prevalent findings in RA, which leads to significant morbidity and mortality.
View Article and Find Full Text PDFClin Rheumatol
January 2025
Faculty of Medicine, Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey.
Objectives: To determine the features of rheumatoid pulmonary nodules and the factors associated with nodule progression in patients with rheumatoid arthritis.
Methods: Between January 2010 and September 2018, RA patients with at least one chest computed tomography (CT) were included. Two experienced radiologists examined chest CTs.
Inflamm Res
January 2025
Department of Biochemistry, Cancer Biology, Neuroscience, and Pharmacology, School of Medicine, Meharry Medical College, 1005 D.B. Todd Jr. Blvd, Nashville, TN, USA.
Background: The aberrant expression of α defensin 5 (DEFA5) protein in colonic inflammatory bowel diseases (IBDs) underlies the distinct pathogenesis of Crohn's colitis (CC). It can serve as a biomarker for differentiating CC from Ulcerative colitis (UC), particularly in Indeterminate colitis (IC) cases into UC and CC. We evaluated the specificity of commercially available anti-DEFA5 antibodies, emphasizing the need to further validate their appropriateness for a given application and highlighting the necessity for novel antibodies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!